Revvity
RVTY
419 hedge funds and large institutions have $10.3B invested in Revvity in 2019 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 127 increasing their positions, 139 reducing their positions, and 28 closing their positions.
161% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 28
26% more capital invested
Capital invested by funds: $8.15B → $10.3B (+$2.14B)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
10% more funds holding
Funds holding: 381 → 419 (+38)
0.27% more ownership
Funds ownership: 96.14% → 96.41% (+0.27%)
9% less repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 139
54% less call options, than puts
Call options by funds: $10.4M | Put options by funds: $22.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$42.6M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$20.9M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$10.9M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$8.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$29.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$28M |
| 3 |
Millennium Management
New York
|
-$19.9M |
| 4 |
Primecap Management
Pasadena,
California
|
-$15.6M |
| 5 |
Goldman Sachs
New York
|
-$11.9M |
RVTY Hedge Fund Activity: Q1 2019 in Review
419 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Revvity (RVTY) for Q1 2019, worth a combined $10.3B — up 26% from $8.15B a quarter earlier.
Buyers outnumbered sellers: 73 funds opened new RVTY positions and 28 closed out — a net gain of 45 holders — while 127 added to existing stakes and 139 trimmed.
The largest buyer was PFM Health Sciences, opening a new position worth an estimated $42.6M. The largest seller was BlackRock, cutting an estimated $29.1M.
- 419 institutional investors held Revvity (RVTY) as of Q1 2019, up from 381 in Q4 2018.
- Funds reported $10.3B of Revvity stock for Q1 2019, up 26% quarter-over-quarter.
- 73 funds opened new Revvity positions in Q1 2019 and 28 closed out, a net change of +45 holders.
- The largest Revvity buyer in Q1 2019 was PFM Health Sciences, an estimated $42.6M added.
- The largest Revvity seller in Q1 2019 was BlackRock, an estimated $29.1M sold.
Based on aggregated 13F filings for Q1 2019.